GH3DORT | TIPP | DPDPE | ICI-174864 | |||
---|---|---|---|---|---|---|
Ki | Uncoupled/Coupled Ratio | Ki | Uncoupled/Coupled Ratio | Ki | Uncoupled/Coupled Ratio | |
nM | nM | nM | ||||
Membranes | ||||||
−GppNHp/NaCl (coupled) | 3.02 ± 0.16 | 14.5 ± 2.22 | 304 ± 73.2 | |||
+GppNHp/NaCl (uncoupled) | 1.16 ± 0.111-150 | 0.384 | 418 ± 51.21-150 | 28.8 | 18.8 ± 3.81-150 | 0.062 |
Permeabilized | ||||||
−GppNHp/NaCl (coupled) | 4.77 ± 1.39 | 13.2 ± 5.6 | 680 ± 46.1 | |||
+GppNHp/NaCl (uncoupled) | 0.42 ± 0.091-150 | 0.088 | 379 ± 61.11-150 | 28.7 | 83.8 ± 5.461-150 | 0.123 |
Competitive inhibition of [3H]diprenorphine binding (1.0 nM) in GH3DORT membranes or in permeabilized cells by TIPP, DPDPE, or ICI-174864 (10−12–10−5 M) in the presence or absence of GppNHp (25 μM) and NaCl (100 mM) was performed as described under Experimental Procedures. Affinity (Ki) values are expressed as mean ± S.E.M. and were calculated from IC50 values derived from complete concentration-effect curves using the Cheng-Prusoff equation (see Figs.1 and 5). The Kd for diprenorphine used to calculate the Ki values in membranes was 0.71 ± 0.04 nM (−GppNHp/NaCl) and 1.06 ± 0.14 nM (+GppNHp/NaCl). TheKd for diprenorphine in permeabilized cells was 1.29 ± 0.11 nM (−GppNHp/NaCl) and 0.93 ± 0.10 nM (+GppNHp/NaCl). Data for each value presented represent three separate experiments performed in duplicate.
↵1-150 Significantly different from corresponding −GppNHp/NaCl (coupled)(P < 0.05, Student's t test).